Pharmacokinetic study of diclophenac sodium in rat plasma by high-performance liquid chromatography

Authors

  • L. V. Brun National University of Pharmacy, Ukraine
  • V. I. Macolinets SE “Sytenko Institute of Spine and Joint Pathology of the National Academy of Medical Sciences of Ukraine”, Ukraine
  • S. N. Gubar National University of Pharmacy, Ukraine

DOI:

https://doi.org/10.24959/ubphj.16.57

Keywords:

pharmacokinetics, nonsteroidal anti-inflammatory drugs, diclofenac sodium, glucosamine, high-performance liquid chromatography

Abstract

The aim of this study is to determine pharmacokinetics of diclofenac sodium in the experiment on rats by the method of high-performance liquid chromatography. Identification and quantitative determination of diclofenac sodium in the substance of diclofenac sodium were carried out by the method of high-performance liquid chromatography. For study conduct, a total of 94 male rats with body weight of 250-300 gwere used. Experimental animals were subdivided into 15 groups. Diclofenac sodium was diluted in purified water and administered per os at the doses of ED50 and ½ ED50, equivalent to 8 mg/kg and 4 mg/kg of animal body weight, respectively. Animals were sacrificed in 15 min, 30 min, 60 min, 90 min, 120 min, 240 min, and 360 after drug administration. For extraction of diclofenac sodium from rat plasma samples, we used a method of solid-phase extraction, which had been modified due to micro-concentrations of the active substance. Dependence of diclofenac sodium concentration on time and dose was studied by the method of high-performance liquid chromatography. In the result of the study, quantitative content of diclofenac sodium substance and suitability of the doses studied (4 mg/kg and 8 mg/kg) were confirmed. The study conducted revealed no dynamics of time, during which diclofenac sodium was present in systemic blood flow, on the dose. The results, which had been proved by chromatograms of diclofenac sodium and control sample (plasma without diclofenac) for each time interval, were obtained. First concentrations of diclofenac sodium in rat plasma are registered in rat plasma in 15 min after dose administration at the doses of 4 and 8 mg/kg. That is why this time index is recommended for further preclinical and clinical studies.

References

Брунь Л.В., Губарь С.М. Розробка методики кількісного визначення диклофенаку натрію в плазмі крові щурів методом високоефективної рідинної хроматографії з урахуванням особливостей аналізу мікро концентрації діючої речовини / Л.В. Брунь, С.М. Губарь // Український біофармацевтичний журнал. – 2016. – № 3 (44). – С. 54-59.

Доклінічні дослідження лікарських засобів / За ред. О.В. Сефанова: Метод. рекомендації.  К.: Авіцена, 2001.  С. 528.

Клиническая фармакология и фармакотерапия (монография) / С.В. Налетов, Т.Д. Бахтеева, В.Н. Казаков, И.А. Зупанец и др. / Под ред. С.В. Налетова. – Севастополь: Вебер, 2005. – 672 с.

Компендиум 2015 – лекарственные препараты / Под ред. В.Н.Ко¬ва-ленко, А.П. Викторова. – К.: Морион, 2015. – 2320 с.

Лапач С.Н., Чубенко А.В., Бабич П.Н. Статистические методы в медико-биологических исследованиях с использованием Excel. – К.: Морион, 2000. – 320 с.

Остеоартроз: консервативная терапия: Монография / Авт. кол.: Н.А.Корж, А.Н. Хвисюк, Н.В. Дедух и др.; Под ред. Н.А.Коржа, Н.В. Дедух, И.А. Зупанца. – Харьков: Золотые страницы, 2007. – 424 с.

Brunner L.A., Luders R.S. An automated method for the determination of diclofenac sodium in human plasma // J. Chromatogr. Sci. – 1991. – Vol.29, № 7. – Р. 287-291.

In vivo bioequivalence guidances (1090) – U.S. Pharmacopeia 23, NF 18. – 1995. – P. 3028 – 3053.

Kamath B.V., Shivram K., Shah A.C. High-perfomance liquid chromatographic method for the determination of diclofenac in human plasma and urine // J. Chromatogr. – 1993. – Vol.12, № 3. – Р. 324-329.

United States Pharmacopea / Official Monographs. – 1995. – P. 546.

Downloads

Published

2016-08-15

Issue

No. 4(45) (2016)

Section

Pharmacology and biochemistry

License

Copyright (c) 2016 National University of Pharmacy

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Authors who publish with this journal agree to the following terms:

  1. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
  2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
  3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).